Inhibitory Antibodies
-
F2091 Anti-ANG2 & VEGFA Antibody (Vanucizumab)Summary: Anti-ANG2 & VEGFA Antibody (Vanucizumab) -
F2092 Anti-Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin)Summary: Anti-Polyubiquitin Antibody (Genentech patent anti-Polyubiquitin) -
F2093 Anti-TGF-β Receptor Antibody (Sotatercept)Summary: Anti-TGF-β Receptor Antibody (Sotatercept) -
F2094 Anti-ADC Antibody Antibody (Cantuzumab)Summary: Anti-ADC Antibody Antibody (Cantuzumab) -
F2095 Anti-Wnt Antibody (Ipafricept)Summary: Anti-Wnt Antibody (Ipafricept) -
F2096 Anti-IL17A/IL-17F Antibody (Bimekizumab)Summary: Anti-IL17A/IL-17F Antibody (Bimekizumab) -
F2097 Anti-Nectin-4 Antibody (Enfortumab)Summary: Anti-Nectin-4 Antibody (Enfortumab) -
F2098 Anti-TNF-α Antibody (Etanercept)Summary: Anti-TNF-α Antibody (Etanercept) -
F2099 Anti-CD70 Antibody (Cusatuzumab)Summary: Anti-CD70 Antibody (Cusatuzumab) -
F2100 Anti-CD20/CD3 Antibody (Mosunetuzumab)Summary: Anti-CD20/CD3 Antibody (Mosunetuzumab)

